Press release
Crohn's Disease Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated)
Crohn's Disease Pipeline
Key Takeaways from the Crohn's Disease Pipeline Report
• DelveInsight's Crohn's Disease report depicts a robust space with 90+ active players working to develop 90+ pipeline therapies for Crohn's Disease treatment.
• The leading companies working in the Crohn's Disease Market include Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, Priothera, SLA Pharma, HAV Vaccines Ltd, Enzo Biochem Inc., VHsquared Ltd., Stero Biotechs, Reistone Biopharma Company Limited, Qu Biologics, Provention Bio, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare, 4D Pharma, Landos Biopharma, Janssen, Protagonist Therapeutics, Roche, Eisai, Bristol-Myers Squibb, Iltoo Pharma, and others.
• Promising Crohn's Disease Pipeline Therapies in the various stages of development include Etrasimod, infliximab, MEDI2070, Filgotinib, Risankizumab 600 mg IV, CP-461, Natalizumab, Adalimumab, Visilizumab, Methoxsalen +ECP, Darvadstrocel, and others.
• April 2024:- Pfizer announced a study of Phase 3 clinical trials for Etrasimod. This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, corticosteroids, immunosuppressants, or biologics). The overall duration of this study is up to 282 weeks, inclusive of the Screening Period, Treatment Period of up to 274 weeks (Induction, Extension or Maintenance, and Long-term Extension Periods), and the 4-Week Follow-Up Period for safety assessment.
Request a sample and discover the recent advances in Crohn's Disease Treatment Drugs @ Crohn's Disease Pipeline Report- https://www.delveinsight.com/report-store/crohns-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Crohn's Disease pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Crohn's Disease drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Crohn's Disease clinical trial landscape.
Crohn's Disease Overview
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, where inflammation extends all the way through the intestinal wall from mucosa to serosa. It is a relapsing and remitting disease.
Find out more about Crohn's Disease Treatment Landscape @ Drugs for Crohn's Disease Treatment- https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Crohn's Disease Emerging Drugs Profile
• Guselkumab: Janssen
• RHB-104: RedHill Biopharma
Crohn's Disease Pipeline Therapeutics Assessment
There are approx. 90+ key companies which are developing the therapies for Crohn's Disease. The Crohn's Disease companies which have their Crohn's Disease drug candidates in the most advanced stage, i.e. Phase III include, Janseen.
Learn more about the emerging Crohn's Disease Pipeline Therapies @ Crohn's Disease Clinical Trials Assessment- https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Crohn's Disease Pipeline Report
• Coverage- Global
• Allergic Conjunctivitis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Allergic Conjunctivitis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Companies- Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, Priothera, SLA Pharma, HAV Vaccines Ltd, Enzo Biochem Inc., VHsquared Ltd., Stero Biotechs, Reistone Biopharma Company Limited, Qu Biologics, Provention Bio, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare, 4D Pharma, Landos Biopharma, Janssen, Protagonist Therapeutics, Roche, Eisai, Bristol-Myers Squibb, Iltoo Pharma, and others.
• Pipeline Therapies- Etrasimod, infliximab, MEDI2070, Filgotinib, Risankizumab 600 mg IV, CP-461, Natalizumab, Adalimumab, Visilizumab, Methoxsalen +ECP, Darvadstrocel, and others.
Dive deep into rich insights for new drugs for Crohn's Disease Treatment, Visit @ Crohn's Disease Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Crohn's Disease: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Crohn's Disease - DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. Crohn's Disease Collaboration Deals
9. Late Stage Products (Registered)
10. Infliximab biosimilar: Amgen
11. Drug profiles in the detailed report…..
12. Late Stage Products (Phase III)
13. Guselkumab: Janssen
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II/III)
16. ABX464: Pfizer
17. Drug profiles in the detailed report…..
18. Mid Stage Products (Phase II)
19. Mocravimod: Priothera
20. Drug profiles in the detailed report…..
21. Early Stage Products (Phase I)
22. IMU-856: Immunic
23. Drug profiles in the detailed report…..
24. Preclinical Stage Products
25. INV-88: Innovimmune Biotherapeutics
26. Drug profiles in the detailed report…..
27. Discovery Stage Products
28. DNL975: Denali Therapeutics
29. Inactive Products
30. Crohn's Disease Key Companies
31. Crohn's Disease Key Products
32. Crohn's Disease- Unmet Needs
33. Crohn's Disease- Market Drivers and Barriers
34. Crohn's Disease- Future Perspectives and Conclusion
35. Crohn's Disease Analyst Views
36. Crohn's Disease Key Companies
37. Appendix
For further information on the Crohn's Disease Pipeline therapeutics, reach out to Crohn's Disease Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Links-
http://demo.advised360.com/read-blog/154799
https://thehealthbridges.com/read-blog/19127
https://app.talkshoe.com/user/joneswilliam/about#google_vignette
https://www.vaca-ps.org/blogs/142022/The-Evolving-Landscape-of-Healthcare-Business-Consulting-Services
https://www.anobii.com/en/01d38d0b9694756e64/profile/activity
https://myanimelist.net/profile/dennydonesgerman
https://forum.pivx.org/threads/healthcare-business-consulting-services-navigating-complexity-in-modern-healthcare.2035/
https://pubhtml5.com/homepage/npvs/
https://b31.org.uk/author/anniesmith9/
https://fairygodboss.com/users/profile/Ix-vMa09gj/Annie-Smith
https://forum.completefrance.com/index.php?/topic/71194-key-areas-of-focus-in-healthcare-consulting-services/
https://educatorpages.com/site/kelleadvin/pages/blog?
https://offgridworld.com/author/anniejones9/
https://www.openhumans.org/member/me/
https://findpenguins.com/5zphebtv0zouo
http://jobs.emiogp.com/author/williamsmith9/
https://www.shippingexplorer.net/en/user/williamsmith9/88249
https://wakelet.com/@DennyDones813
https://startupxplore.com/en/person/denny-dones
https://www.nfpjobs.com.au/employers/1939365-delveinsight
https://community.hodinkee.com/members/dennydoness
https://jobs.mikeroweworks.org/employers/1930150-delveinsight
https://www.social-vape.com/read-blog/132516
https://codex.core77.com/users/dennydones9
https://www.newjerseyhunter.com/members/dennydones1.84566/#about
https://au.blurb.com/user/dennydones9?profile_preview=true
https://trabajo.merca20.com/author/kelleadvin/
https://www.atlasobscura.com/users/dennydones1
https://www.mixcloud.com/dennydones1/
https://www.designspiration.com/ybhardwaj/
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website:- https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crohn's Disease Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated) here
News-ID: 3475011 • Views: …
More Releases from DelveInsight Business Research LLP
Addison's Disease Market Outlook Report 2032 |Akorn Operating Co., Amneal Pharma …
DelveInsight's "Addison's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Addison's Disease, historical and forecasted epidemiology as well as the Addison's Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Addison's Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Addison's Disease market size…
Anemia In Chronic Kidney Disease Market Outlook Report 2032 | 3SBio, UBI Pharma …
DelveInsight's "Anemia In Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Anemia In Chronic Kidney Disease, historical and forecasted epidemiology as well as the Anemia In Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Anemia In Chronic Kidney Disease market report provides current treatment practices, emerging drugs, the market share of…
Visceral Pain associated with GI disorders Market Outlook Report 2032 | Addex Th …
DelveInsight's "Visceral Pain associated with GI disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Visceral Pain associated with GI disorders, historical and forecasted epidemiology as well as the Visceral Pain associated with GI disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Visceral Pain associated with GI disorders market report provides current treatment practices, emerging drugs,…
Glabellar Frown Lines Market Report Outlook 2032 | Allergan, Galderma, Merz Phar …
DelveInsight's "Glabellar Frown Lines Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Glabellar Frown Lines, historical and forecasted epidemiology as well as the Glabellar Frown Lines market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Glabellar Frown Lines market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
More Releases for Crohn
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drug Market 2020 Recent Industry Developments and Growth Strateg …
ReportsnReports provides in depth study of "Crohn’s Disease Drug Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Crohn’s Disease Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organisation such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organisation.
The global…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025.
This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson
Pfizer
Sanofi
Merck
GSK
AbbVie
Takeda
Ferring
UCB
Boehringer Ingelheim
Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Crohn Disease can be split into
Small Intestine and Ileocephalitis
Colon Disease
Market segment…
